Poster Presentation
Biography
Samia Bouledoua, Research Professor in Mineral Chemistry at the Faculty of Medicine, Université BADJI Mokhtar .Annaba (Algeria), is currently working on her PhD in Nanoscience and Nanotechnology
Abstract
The nanoparticles have attracted great interest due to their unique physical and chemical properties, and zinc oxide (ZnO) is one of metal oxide nanoparticles, which attracts considerable attention due to its unique characteristics and its wide range of important technological applications. Nanocomposites are characterized by a combination of inorganic materials in the same particle. These assemblies have properties ranging from those of each of the constituents. The properties of ZnO nanoparticles can be improved depending on the interest of doping research with different metal atoms to meet specific needs and applications. Therefore, doping in the host matrix of zinc oxide nanoparticles with appropriate elements can adjust different properties of ZnO and is an effective method for improving and controlling its properties, which is crucial for its practical applications. Mg-doped ZnO is of considerable interest because of its unique optical, electrical and piezoelectric characteristics. Our work consists in the synthesis of a ZnO / Mg nanocomposite by a chemical coprecipitation method. The characterization of the synthesized nanocomposite was determined by X-ray diffraction (XRD) and UV-visible spectrophotometry. The DRX, on the one hand, makes it possible to determine the crystalline structure of the nanocomposite which is of wurtzite type, and secondly to calculate the size of crystallites obtained by the application of the Scherrer equation in the diameter of 49.44 nm. The UV visible spectrophotometry meanwhile revealed the existence of a maximum absorbance at 372 nm and allowed to assert that the synthesized powder corresponds to ZnO / Mg nanocomposites.
Biography
Alaimo A is a Young Assistant Researcher at the National Scientific and Technical Research Council (Spanish: Consejo Nacional de Investigaciones CientÃficas y Técnicas, CONICET), the Argentine government agency, which directs and co-ordinates most of the scientific and technical research done in universities and institutes. She is a highly motivated and innovative Cellular and Molecular Biologist with specialization in Mitochondria biology, Molecular genetics, Cell biology, Biochemistry and Nanotechnology. She is an enthusiastic team player adept at providing leadership, while also learning from fellow team members.
Abstract
Age-related macular degeneration (AMD) is a progressive retinal disease and is the leading cause of visual impairment in elderly people in western countries, for which there is still no cure. Genetics, environmental insults, and age-related issues are risk factors for the development of the disease and all these are linked to oxidative stress induction. Also, degeneration of retinal pigment epithelial cells (RPE) is a crucial causative factor responsible for the onset and progression of AMD. With the population aging, AMD will gradually become in a globally prevalent disease. The decline in the quality of life among affected patients highlights a critical need for developing preventive strategies. In this sense, phytochemicals with both antioxidant and anti-inflammatory properties may have a potential role in the prevention and treatment of this ocular disease. Particularly, there is an increased interest in the therapeutic effects of resveratrol (RSV). RSV is a naturally occurring polyphenolic compounds from the stilbenes family, mainly found in black grape and peanuts. RSV has beneficial effects on human health, including its neuroprotection, anti-inflammatory action, potent antioxidant activity and antiaging effects. Our research line is focused in investigating the protective effectiveness of RSV in an in vitro model of AMD. In addition, we designed and developed chitosan-based nanocarriers for RSV encapsulation to overcome physicochemical and pharmacokinetic limitations such as poor oral bioavailability, low water solubility and photosensibility. In summary, chitosan nanoparticles are a promising platform for ocular bioactives (eg. RSV) delivery for therapeutic intervention against oxidative stress-associated diseases, such as AMD
Biography
Oznur Aglar has completed her Master’s degree in Organic Chemistry at Umea University, Sweden, in 2016. She is currently a second-year PhD doctoral student in Analytical Chemistry at the University of Potsdam. Her current research focuses on the study of protein-ligand interactions, including binding affinity and binding kinetics by NMR.
Abstract
Ceramide, an important component in the metabolism of sphingolipids, plays a significant role in proliferation, and apoptosis of cells. De novo synthesis of ceramide takes place at the cytosolic surface of the endoplasmic reticulum (ER), and then, ceramide is transferred to the Golgi apparatus for conversion into sphingomyelin and glucosphingolipids, mainly by nonvesicular trafficking. Non-vesicular transport of ceramide is carried out by the ceramide transfer protein (CERT) that consists of peptidic motifs and multiple domains. The C-terminal (StAR)- related lipid transfer (START) domain is the most important domain given the fact that it is capable of extracting and accommodating ceramide in its deep hydrophobic cavity. CERT could be an attractive pharmacological target because of its involvement in common pathological processes such as Alzheimer's disease, infectious diseases and cancer. A well-known antagonist of CERT is -N-(3-hydroxy-1-hydroxymethyl-3-phenylpropyl) dodecanamide (HPA-12), however, there is only limited structure-activity relationship (SAR) data available. In this study, we aim to explore the interaction between CERT and HPA-12 to establish SAR of this compound class by nuclear magnetic resonance spectroscopy (NMR) in order to improve the inhibition activity of the ligand for a potential drug design. Herein, we optimized the established expression and purification protocols to get a good yield of the monomer of the START domain. In order to get an idea about the suitability of the protein of interest for ligand and receptor-based NMR experiments, the target protein was labeled with 15N and purified using an optimized three step purification method. The 15N labeled START domain’s monomer was used to record initial 1H - 15N HSQC and TROSY NMR spectra in phosphate buffer. Results of both HSQC and TROSY experiments were promising for further receptor based NMR experiments